| Literature DB >> 24101494 |
Malene B Vester-Christensen1, Adnan Halim, Hiren Jitendra Joshi, Catharina Steentoft, Eric P Bennett, Steven B Levery, Sergey Y Vakhrushev, Henrik Clausen.
Abstract
The metazoan O-mannose (O-Man) glycoproteome is largely unknown. It has been shown that up to 30% of brain O-glycans are of the O-Man type, but essentially only alpha-dystroglycan (α-DG) of the dystrophin-glycoprotein complex is well characterized as an O-Man glycoprotein. Defects in O-Man glycosylation underlie congenital muscular dystrophies and considerable efforts have been devoted to explore this O-glycoproteome without much success. Here, we used our SimpleCell strategy using nuclease-mediated gene editing of a human cell line (MDA-MB-231) to reduce the structural heterogeneity of O-Man glycans and to probe the O-Man glycoproteome. In this breast cancer cell line we found that O-Man glycosylation is primarily found on cadherins and plexins on β-strands in extracellular cadherin and Ig-like, plexin and transcription factor domains. The positions and evolutionary conservation of O-Man glycans in cadherins suggest that they play important functional roles for this large group of cell adhesion glycoproteins, which can now be addressed. The developed O-Man SimpleCell strategy is applicable to most types of cell lines and enables proteome-wide discovery of O-Man protein glycosylation.Entities:
Keywords: O-glycosylation; Orbitrap; POMGnT1; glycoproteomics; mass spectrometry
Mesh:
Substances:
Year: 2013 PMID: 24101494 PMCID: PMC3876253 DOI: 10.1073/pnas.1313446110
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205